0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Pediatric Forum |

Trial Effect in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia

Ketan Prasad Kulkarni, MD; Laxman Singh Arya, MD
Arch Pediatr Adolesc Med. 2010;164(9):882-883. doi:10.1001/archpediatrics.2010.141.
Text Size: A A A
Published online

Extract

We read with interest the article by Koschmann and colleagues1 describing the lack of trial effect in patients with newly diagnosed acute lymphoblastic leukemia (ALL). However, we have some reservations regarding the conclusions and its potential impact as described. A recent article from Texas confirms that there is a wide variation in the percentage of patients enrolled in cancer clinical trials in different centers owing to variations in ethnicity, geography, health care services, and vulnerable population subgroups.2 It is likely that the percentage of patients accrued on a trial could vary widely among different centers owing to available trials and inclusion criteria that could impact outcome.2 A recent study describes the effect of the center where the cancer was treated on outcome of adolescent cancer patients and underscores the importance of Children's Oncology Group cooperative studies.3

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
[Treatment of acute Leukemia]. Gan To Kagaku Ryoho 2014;41(5):560-6.
Jobs
brightcove.createExperiences();